| Primary |
| Hiv Infection |
76.0% |
| Antiretroviral Therapy |
10.7% |
| Acquired Immunodeficiency Syndrome |
1.6% |
| Tuberculosis |
1.5% |
| Cerebral Toxoplasmosis |
1.1% |
| Prophylaxis Against Hiv Infection |
1.1% |
| Brain Oedema |
0.9% |
| Hiv Test Positive |
0.8% |
| Infection Prophylaxis |
0.8% |
| Mycobacterium Avium Complex Infection |
0.8% |
| Cytomegalovirus Infection |
0.6% |
| Progressive Multifocal Leukoencephalopathy |
0.6% |
| Prophylaxis |
0.6% |
| Acute Hiv Infection |
0.4% |
| Antifungal Prophylaxis |
0.4% |
| Blood Triglycerides Increased |
0.4% |
| Pulmonary Hypertension |
0.4% |
| Allergenic Desensitisation Procedure |
0.3% |
| Arthralgia |
0.3% |
| Depression |
0.3% |
|
| Renal Failure Acute |
14.0% |
| Osteonecrosis |
12.4% |
| Drug Resistance |
10.7% |
| Nephrolithiasis |
5.8% |
| Vomiting |
5.8% |
| Weight Decreased |
5.8% |
| Pulmonary Hypertension |
5.0% |
| Drug Exposure During Pregnancy |
4.1% |
| Ventricular Septal Defect |
4.1% |
| Death |
3.3% |
| Pregnancy |
3.3% |
| Reversible Posterior Leukoencephalopathy Syndrome |
3.3% |
| Small For Dates Baby |
3.3% |
| Tracheomalacia |
3.3% |
| Uveitis |
3.3% |
| Cryptorchism |
2.5% |
| Fallot's Tetralogy |
2.5% |
| Hypospadias |
2.5% |
| Immune Reconstitution Syndrome |
2.5% |
| Meningitis Aseptic |
2.5% |
|
| Secondary |
| Hiv Infection |
72.4% |
| Drug Use For Unknown Indication |
5.3% |
| Hiv Test Positive |
3.7% |
| Product Used For Unknown Indication |
3.1% |
| Acquired Immunodeficiency Syndrome |
2.9% |
| Infection Prophylaxis |
1.5% |
| Drug Exposure During Pregnancy |
1.3% |
| Pulmonary Hypertension |
1.2% |
| Hiv Infection Cdc Group Iv Subgroup C1 |
1.0% |
| Prophylaxis |
0.9% |
| Haemarthrosis |
0.8% |
| Human Immunodeficiency Virus Transmission |
0.8% |
| Staphylococcal Infection |
0.8% |
| Antiretroviral Therapy |
0.8% |
| Non-hodgkin's Lymphoma |
0.7% |
| Prophylaxis Against Hiv Infection |
0.7% |
| Antiviral Treatment |
0.6% |
| Antiviral Prophylaxis |
0.5% |
| Arthralgia |
0.5% |
| Insomnia |
0.5% |
|
| Progressive External Ophthalmoplegia |
15.2% |
| Drug Exposure During Pregnancy |
14.3% |
| Pulmonary Hypertension |
10.7% |
| Rhinitis |
5.4% |
| Urinary Sediment Abnormal |
5.4% |
| Renal Failure |
4.5% |
| Renal Failure Acute |
4.5% |
| Speech Disorder |
4.5% |
| Palpitations |
3.6% |
| Parkinsonism |
3.6% |
| Renal Atrophy |
3.6% |
| Vomiting |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Death |
2.7% |
| Pregnancy |
2.7% |
| Proteinuria |
2.7% |
| Thrombocytopenia |
2.7% |
| Virologic Failure |
2.7% |
| Weight Decreased |
2.7% |
| Diarrhoea |
1.8% |
|
| Concomitant |
| Hiv Infection |
54.7% |
| Drug Use For Unknown Indication |
9.0% |
| Acquired Immunodeficiency Syndrome |
8.2% |
| Hepatitis C |
5.7% |
| Atypical Mycobacterial Infection |
4.3% |
| Product Used For Unknown Indication |
3.5% |
| Weight Decreased |
1.8% |
| Trigeminal Neuralgia |
1.6% |
| Diarrhoea |
1.4% |
| Factor Viii Deficiency |
1.4% |
| Depression |
1.2% |
| Drug Exposure During Pregnancy |
1.0% |
| Headache |
1.0% |
| Prophylaxis Against Hiv Infection |
1.0% |
| Hyperuricaemia |
0.8% |
| Prophylaxis |
0.8% |
| Anxiety |
0.6% |
| Breakthrough Pain |
0.6% |
| Hiv Test Positive |
0.6% |
| Musculoskeletal Pain |
0.6% |
|
| Renal Failure Acute |
16.1% |
| White Blood Cell Count Decreased |
12.5% |
| Pseudomembranous Colitis |
10.7% |
| Optic Neuritis Retrobulbar |
7.1% |
| Transaminases Increased |
5.4% |
| Urticaria |
5.4% |
| Convulsion |
3.6% |
| Death |
3.6% |
| Diabetes Mellitus |
3.6% |
| Eyelid Ptosis |
3.6% |
| Hepatitis Chronic Active |
3.6% |
| Hyperlipidaemia |
3.6% |
| Renal Impairment |
3.6% |
| Therapeutic Response Decreased |
3.6% |
| Type 2 Diabetes Mellitus |
3.6% |
| Wrong Technique In Drug Usage Process |
3.6% |
| Anogenital Dysplasia |
1.8% |
| Anogenital Warts |
1.8% |
| Anxiety |
1.8% |
| Aspartate Aminotransferase Increased |
1.8% |
|
